Sam Altman is like a juggler on a unicycle. Building all-knowing chatbots powered by cutting-edge artificial-intelligence models is too meek an ambition for OpenAI’s boss. To keep his audience rapt, ...

Seedream 4.5 API, developed by ByteDance, marks a significant leap forward in AI image models. With AI image generation capabilities, businesses and developers are now equipped with powerful tools ...

Volatility forecasting is a key component of modern finance, used in asset allocation, risk management, and options pricing. Investors and traders rely on precise volatility models to optimize ...

Hyderabad-based pharmaceutical manufacturer SCL Lifesciences Ltd (formerly Saurav Chemicals) is eyeing its maiden round of external funding, at least two people ..... Follow VCCircle on Google News ...

Creating custom outfits in "Roblox" has become one of the most popular ways for young creators to express themselves and even earn Robux. Whether you enjoy fashion, want to design your own style, or ...

Cdymax Pharma has been slapped with a warning letter from the FDA outlining two observations against the Bangalore, India-based API maker, both linked to testing shortfalls. The letter comes in ...

Nov 7 (Reuters) - Indian drugmaker Divi's Laboratories (DIVI.NS), opens new tab reported second-quarter profit above analysts' estimates on Friday, helped by its business that focuses on customised ...

Thinking Machines, the AI startup founded earlier this year by former OpenAI CTO Mira Murati, has launched its first product: Tinker, a Python-based API designed to make large language model (LLM) ...

I remember specifically being at my daughter's house when my grandson asked if he could play some of his video games. My daughter told him that he could play one of his games, but he could not play ...

Today, a brief rundown of news involving Kriya Therapeutics and Odyssey Therapeutics, as well as updates from Amgen, Regeneron and Merck & Co. that you may have missed.

India’s Hikal Limited has been hit with an FDA warning letter chiding the drug ingredients manufacturer for failing to uncover the cause of dozens of complaints of metal contamination in its products.